DANIELLE BOUCHARD: Open Payments
NPI 1396261863 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,628 in 72 payments from 18 companies in 2025. Trend: 2023 $383 · 2024 $1,282 · 2025 $1,628
Food & beverage: $1,628
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $287 |
| Actelion Pharmaceuticals US, Inc. | 5 | $209 |
| Amgen Inc. | 9 | $153 |
| AstraZeneca Pharmaceuticals LP | 7 | $147 |
| BridgeBio Pharma, Inc. | 5 | $132 |
| Novo Nordisk Inc | 4 | $115 |
| Alnylam Pharmaceuticals Inc. | 4 | $100 |
| PFIZER INC. | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Merck Sharp & Dohme LLC | 3 | $65 |
Products named: CAMZYOS, REPATHA, Attruby, UPTRAVI, ELIQUIS, Wegovy, VYNDAQEL, ONPATTRO.
Industry payments across MA — which companies pay providers there.
